Syngene International Limited has inaugurated its state-of-the-art Clinical Translational Sciences Laboratory in Bengaluru. The milestone event was celebrated by Executive Chairperson Dr. Kiran Mazumdar Shaw, CEO Siddharth Mittal, and senior company leadership.
Aligned with the core philosophy of “doing science that matters,” the new facility bridges the critical gap between discovery research and clinical operations. By integrating real patient samples with deep translational insights, the laboratory enables researchers to move from raw data generation to clinical decision-making faster and more effectively.
For Syngene’s global clients, this advanced facility offers a deeper biological understanding of diseases, more cost-efficient clinical programs, and a seamless development continuum. By connecting discovery directly to clinical application, the laboratory eliminates isolated handoffs, ensuring smoother translation of laboratory science to real-world medical solutions.
Unlike conventional labs that focus solely on data collection, this facility is engineered to detect diseases much earlier and precisely match the right patients with targeted therapies. Ultimately, this strategic expansion strengthens Syngene’scapability to deliver highly precise, life-saving outcomes for patients worldwide.
Written by: Pragna Biswas
Graphics by: Pramit Hazra
